About Actipulse Neuroscience
Actipulse Neuroscience is a company based in Cambridge (United States) founded in 2017 by Adrien Chatillon and Gabriel Villafuerte.. Actipulse Neuroscience has raised $125 thousand across 3 funding rounds from investors including Y Combinator, MassChallenge and Start-Up Chile. Actipulse Neuroscience operates in a competitive market with competitors including Newronika, NovaVision, MindAffect, EnClear Therapies and AccuMedical, among others.
- Headquarter Cambridge, United States
- Founders Adrien Chatillon, Gabriel Villafuerte
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Actipulse Neuroscience, Inc.
-
Annual Revenue
$173.96 K6568as on Dec 31, 2022
-
Net Profit
$9.31 K138as on Dec 31, 2022
-
EBITDA
-
Total Equity Funding
$125 K (USD)
in 3 rounds
-
Latest Funding Round
$125 K (USD), Seed
Jan 22, 2022
-
Investors
Y Combinator
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Software Development Team
3 people
Leadership Team
1 people
Research Team
1 people
Almacenista Team
1 people
Unlock access to complete
Funding Insights of Actipulse Neuroscience
Actipulse Neuroscience has successfully raised a total of $125K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $125 thousand completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $125,000
-
First Round
First Round
(04 May 2018)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2022 | Amount | Seed - Actipulse Neuroscience | Valuation | Y Combinator |
|
| Oct, 2019 | Amount | Grant - Actipulse Neuroscience | Valuation |
investors |
|
| May, 2018 | Amount | Grant - Actipulse Neuroscience | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Actipulse Neuroscience
Actipulse Neuroscience has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Y Combinator, MassChallenge and Start-Up Chile. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location | |
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Founded Year | Domain | Location | |
|
Government-backed startup accelerator programs are operated in Chile.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Actipulse Neuroscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Actipulse Neuroscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Actipulse Neuroscience Comparisons
Competitors of Actipulse Neuroscience
Actipulse Neuroscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Newronika, NovaVision, MindAffect, EnClear Therapies and AccuMedical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical devices for neurodegenerative diseases are developed.
|
|
| domain | founded_year | HQ Location |
Non-invasive devices are developed for vision restoration in stroke survivors.
|
|
| domain | founded_year | HQ Location |
Brain-computer interface headsets are developed for patient communication.
|
|
| domain | founded_year | HQ Location |
Developer of device-based therapies to treat neurodegenerative disorders
|
|
| domain | founded_year | HQ Location |
Neurovascular interventional devices for neurological disorders are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Actipulse Neuroscience
Frequently Asked Questions about Actipulse Neuroscience
When was Actipulse Neuroscience founded?
Actipulse Neuroscience was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Actipulse Neuroscience located?
Actipulse Neuroscience is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Who is the current CEO of Actipulse Neuroscience?
Adrien Chatillon is the current CEO of Actipulse Neuroscience. They have also founded this company.
Is Actipulse Neuroscience a funded company?
Actipulse Neuroscience is a funded company, having raised a total of $125K across 3 funding rounds to date. The company's 1st funding round was a Grant of $40K, raised on May 04, 2018.
What is the annual revenue of Actipulse Neuroscience?
Annual revenue of Actipulse Neuroscience is $173.96K as on Dec 31, 2022.
What does Actipulse Neuroscience do?
Actipulse Neuroscience was founded in 2017 in Cambridge, United States, within the biotechnology sector. Non-invasive devices utilizing high-frequency magnetic pulses for transcranial neuromodulation are developed to address pathogenic mechanisms in neurodegenerative disorders. Combination therapies involving drugs and neuromodulation technology are also pursued. Operations focus on research and development of these medical technologies.
Who are the top competitors of Actipulse Neuroscience?
Actipulse Neuroscience's top competitors include Newronika, NovaVision and EnClear Therapies.
Who are Actipulse Neuroscience's investors?
Actipulse Neuroscience has 3 investors. Key investors include Y Combinator, MassChallenge, and Start-Up Chile.